Price Alert

Virax Biolabs Group Limit... (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.63

-0.01 (-1.16%)

At close: Sep 25, 2025, 3:59 PM

0.63

0.38%

After-hours: Sep 25, 2025, 04:00 PM EDT

-1.16% (1D)

Bid	0.62
Market Cap	2.71M
Revenue (ttm)	84.87K
Net Income (ttm)	-6.58M
EPS (ttm)	-1.62
PE Ratio (ttm)	-0.39
Forward PE	-0.64
Analyst	Buy
Dividends	n/a

Ask	0.64
Volume	78,394
Avg. Volume (20D)	600,952
Open	0.64
Previous Close	0.64
Day's Range	0.63 - 0.64
52-Week Range	0.52 - 3.62
Beta	1.62
Ex-Dividend Date	n/a

About VRAX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VRAX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

11 months ago

+50%

Virax Biolabs shares are trading higher after the ... Unlock content with Pro Subscription

News

5 months ago · benzinga.com

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

H.C. Wainwright initiated coverage on Virax Biolabs Group Limited VRAX, a U.K.-based company focused on detecting immune responses and diagnosing viral diseases.